Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
Clinical trial NCT07711314 · RECRUITING
Trial details
- NCT number
- NCT07711314
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.